Trial Profile
Open-label Treatment Extension Study for Patients Who Complete Study RNA200103-201
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 15 May 2019
Price :
$35
*
At a glance
- Drugs Pradefovir (Primary) ; Adefovir dipivoxil
- Indications Hepatitis B
- Focus Adverse reactions; Therapeutic Use
- Sponsors Bausch Health Companies
- 23 Oct 2018 New trial record